External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ira Dunkel, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- University of Colorado Health Sciences Center
Denver, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- Md Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Children'S Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
- John Hopkins Medical Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Children'S Mercy Hospital & Clinics
Kansas City, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2009
- Primary completion
- 15 Jan 2018
- Completion
- 15 Jan 2018
- Last update posted
- 14 Mar 2022
- Registered enrollment
- 47
- Registry id
- NCT01012609
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.